These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3761754)

  • 1. Beneficial effect of OKY-046, a selective thromboxane A2 synthetase inhibitor, on experimental cerebral vasospasm.
    Komatsu H; Takehana Y; Hamano S; Ujiie A; Hiraku S
    Jpn J Pharmacol; 1986 Jul; 41(3):381-91. PubMed ID: 3761754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581.
    Sasaki T; Wakai S; Asano T; Takakura K; Sano K
    J Neurosurg; 1982 Jul; 57(1):74-82. PubMed ID: 7201009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin and thromboxane in cerebral vasospasm II: Effects of thromboxane synthetase inhibitor (OKY-1581) on experimentally-induced cerebral vasospasm.
    Yabuno N
    Acta Med Okayama; 1984 Jun; 38(3):239-50. PubMed ID: 6380217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the prostacyclin-thromboxane system in cerebral vasospasm following induced subarachnoid hemorrhage in the rabbit.
    Chan RC; Durity FA; Thompson GB; Nugent RA; Kendall M
    J Neurosurg; 1984 Dec; 61(6):1120-8. PubMed ID: 6389786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
    Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H
    Stroke; 1985; 16(2):241-4. PubMed ID: 3883580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beneficial effect of a selective TXA2 synthetase inhibitor, OKY-046, both on thromboxane B2 production and vascular damage after spinal cord injury in rat spinal cord].
    Morimoto K; Ikata T; Tounai T
    Nihon Seikeigeka Gakkai Zasshi; 1990 Jan; 64(1):82-8. PubMed ID: 2319197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibitory effects of OKY-046.HCl, a selective thromboxane (TX) A2 synthetase inhibitor, on platelet activating factor (PAF)-induced airway hyperresponsiveness in guinea pigs].
    Takehana Y; Hamano S; Kikuchi S; Kusama H; Komatsu H; Okegawa T; Ikeda S
    Nihon Yakurigaku Zasshi; 1990 Jan; 95(1):21-30. PubMed ID: 2303203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.
    Gomi T; Ikeda T; Ishimitsu T; Uehara Y
    Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
    Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
    Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thromboxane synthetase inhibitors (OKY-046, OKY-1580) on experimentally induced air embolism in anesthetized dogs.
    Ishihara Y; Uchida Y; Kitamura S
    Prostaglandins Leukot Med; 1986 Feb; 21(2):197-206. PubMed ID: 3457388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological studies on the TXA2 synthetase inhibitor (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid (OKY-046).
    Hiraku S; Taniguchi K; Wakitani K; Omawari N; Kira H; Miyamoto T; Okegawa T; Kawasaki A; Ujiie A
    Jpn J Pharmacol; 1986 Jul; 41(3):393-401. PubMed ID: 3093741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an experimental model of acute myocardial infarction and the effects of a thromboxane synthetase inhibitor (OKY-046).
    Tomoda H
    Am Heart J; 1986 Oct; 112(4):696-704. PubMed ID: 3532743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome.
    Niwa T; Maeda K; Shibata M; Yamada K
    Clin Nephrol; 1988 Nov; 30(5):276-81. PubMed ID: 3214971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a selective thromboxane synthetase inhibitor (OKY-046) in patients with coronary artery disease during exercise.
    Shikano M; Ito T; Ogawa K; Satake T
    Jpn Heart J; 1987 Sep; 28(5):663-74. PubMed ID: 3323562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of subarachnoid hemorrhage and a thromboxane A2 synthetase inhibitor on intracranial prostaglandins.
    Yokota M; Tani E; Fukumori T; Maeda Y; Yamaura I
    Surg Neurol; 1991 May; 35(5):345-9. PubMed ID: 2028380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on endotoxin-induced lung injury in unanesthetized sheep.
    Kubo K; Kobayashi T
    Am Rev Respir Dis; 1985 Sep; 132(3):494-9. PubMed ID: 3898941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arachidonic acid induced platelet aggregation and thromboxane formation is inhibited by OKY-1581.
    Uotila P; Matintalo M; Dahl ML
    Prostaglandins Leukot Med; 1983 Nov; 12(3):299-303. PubMed ID: 6419237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic thromboxane inhibition preserves function of rejecting rat renal allografts.
    Coffman TM; Ruiz P; Sanfilippo F; Klotman PE
    Kidney Int; 1989 Jan; 35(1):24-30. PubMed ID: 2651752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical study on effect of thromboxane A2 synthetase inhibitor (OKY-046) to clarify the regulation of cerebral blood flow in cerebral thrombosis.
    Nihei C; Metoki H; Shimanaka Y; Kawahara R; Komatsu O; Oike Y; Kanazawa T; Izawa M; Kaneko H; Hoshi Y
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():953-7. PubMed ID: 2960210
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of selective inhibitor of thromboxane A2 synthetase on cerebral vasospasm after early surgery.
    Tani E; Maeda Y; Fukumori T; Nakano M; Kochi N; Morimura T; Yokota M; Matsumoto T
    J Neurosurg; 1984 Jul; 61(1):24-9. PubMed ID: 6539367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.